OnCo

CD40 sits on the cells that teach T cells what to attack. Agonist antibodies press it to turn cold tumours hot; the strongest signals so far are in pancreatic cancer with chemotherapy. This dossier gathers the 0 products (0 approved), 0 trials, 0 pathways and 0 resistance routes in the corpus that involve it, with external identifiers so it can be joined to UniProt, ChEMBL, Open Targets and the rest of biology.

Biology

A TNF-receptor-superfamily member on antigen-presenting cells; the target of the CD40 agonist technology.

Where it is found
  • B cells and primary carcinomas (UniProt P25942)
  • Dendritic cells and macrophages, per Vonderheide 2020
  • Pancreatic cancer trials of CD40 agonists
Class: surface antigen · Gene: CD40 · Facts checked 2026-09-24 · Target page

External identifiers

Built from HGNC, Ensembl, UniProt and ChEMBL ids

Products by modality and phase

Browse products →

No product in the corpus is aimed at this target yet.

No trial in the corpus names this target or one of its products.

Resistance routes

Unaddressed routes →

The resistance atlas has no route that names this target.

No pathway diagram carries this target as a node.

Companion diagnostics

Assay registry →

No companion diagnostic in the registry measures this target.

Preclinical models

All models →

No model entry for this target yet; check the cancer entries on the models page.

No open questions recorded for this target yet. Suggest one.

Literature

Preprints →
Latest papers · live from Europe PMC
Open in Europe PMC

Query for this target: (TITLE:"CD40" OR ABSTRACT:"CD40" OR TITLE:"TNFRSF5" OR ABSTRACT:"TNFRSF5" OR TITLE:"CD40 molecule" OR ABSTRACT:"CD40 molecule" OR TITLE:"Bp50" OR ABSTRACT:"Bp50" OR TITLE:"p50" OR ABSTRACT:"p50") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about CD40, not a curated reading list.

Export

The dossier as machine-readable JSON: identifiers from HGNC, Ensembl, UniProt and ChEMBL, products with status, trials, pathways, hotspots, open questions and assays. The full entity record is in the open API at /api/v1/entities/cd40.json. Licence CC BY-NC 4.0.